Articles From: Shire Delivers Record Revenues and Non GAAP Earnings per ADS in 2014, and Enters 2015 With Strongest-Ever Pipeline to ShoeBuy Opens the Box to Reveal its New Approach to Confident Online Shopping


2015/2/12
DUBLIN, Ireland , February 12, 2015 /PRNewswire/ -- Product sales grew 5% excluding products acquired with ViroPharma.
Sign-up for Shire Delivers Record Revenues and Non GAAP Earnings per ADS in 2014, and Enters 2015 With Strongest-Ever Pipeline investment picks
2015/1/30
By Jonathan D.
Sign-up for Shire Drug Cleared to Treat Binge-Eating Disorder investment picks
2015/1/30
By Jonathan D.
Sign-up for Shire Drug Cleared to Treat Binge-Eating Disorder -- Update investment picks
2015/2/25
Shire PLC (SHPG) filed a Form 8K - Acquisition or Disposition of Assets - with the U.S Securities and Exchange Commission on February 25, 2015.
Sign-up for Shire Files 8K - Asset Acquisition Or Disposition investment picks
2015/2/12
Shire PLC (SHPG) filed a Form 8K - Changes in Company Executive Management - with the U.S Securities and Exchange Commission on February 12, 2015.
Sign-up for Shire Files 8K - Changes Executive Management investment picks
2015/2/25
Shire PLC (SHPG) filed a Form 8K - Direct or off-Balance Sheet Financial Obligation - with the U.S Securities and Exchange Commission on February 25, 2015.
Sign-up for Shire Files 8K - Direct Or Off-Balance Sheet Financial Obligation investment picks
2015/2/2
Shire PLC (SHPG) filed a Form 8K - Other Events - with the U.S Securities and Exchange Commission on February 02, 2015.
Sign-up for Shire Files 8K - Other Events investment picks
2015/2/4
Shire PLC (SHPG) filed a Form 8K - Other Events - with the U.S Securities and Exchange Commission on February 03, 2015.
Sign-up for Shire Files 8K - Other Events investment picks
2015/2/13
Shire PLC (SHPG) filed a Form 8K - Other Events - with the U.S Securities and Exchange Commission on February 13, 2015.
Sign-up for Shire Files 8K - Other Events investment picks
2015/2/25
Shire PLC (SHPG) filed a Form 8K - Regulation FD Disclosure - with the U.S Securities and Exchange Commission on February 25, 2015.
Sign-up for Shire Files 8K - Regulation FD investment picks
2015/2/12
By Jonathan D.
Sign-up for Shire Profit Surges Thanks to AbbVie Breakup Fee -- 2nd Update investment picks
2015/2/12
(Adds details, background.) By Marta Falconi Shire PLC (SHPG) said Thursday a one-time break-up fee related to a failed merger pushed fourth-quarter profits sharply higher, but cautioned its rate of sales growth may slow this year.
Sign-up for Shire Profit Surges, Warns on Slowdown in Sales - Update investment picks
2014/12/10
LEXINGTON, Massachusetts , December 10, 2014 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPG) is hosting a Research and Development (R&D) Day for the investment community focused on the Company's pipeline of innovative medicines being developed to treat rare diseases and other specialty conditions.
Sign-up for Shire R&D Day Profiles Innovative Pipeline Expected to Contribute $3 Billion in Product Sales by 2020 investment picks
2015/2/12
By Marta Falconi Dublin-based pharmaceutical company Shire PLC (SHPG) said fourth-quarter net income rose to $2.17 billion, compared with $64 million in the same period a year earlier, boosted by a one-time gain of $1.64 billion.
Sign-up for Shire Sees Surge in 4Q Profit investment picks
2015/2/6
By Carla Mozee, MarketWatch LONDON (MarketWatch) -- U.K. stocks fell Friday, with shares of Shire PLC pushed lower after the pharmaceutical maker was criticized over tax avoidance, but the benchmark FTSE 100 remained on track for a weekly gain.
Sign-up for Shire shares fall in London; FTSE 100 eyes weekly rise investment picks
2015/1/12
By Carla Mozee, MarketWatch LONDON (MarketWatch) -- U.K. stocks rose Monday, with shares of Shire PLC gaining after the Irish drug maker agreed to a multibillion-dollar purchase of NPS Pharmaceuticals Inc. The FTSE 100 rose 0.3% to 6,522.03, winning back a small slice of Friday's 1.1% drop, which was led by a broker downgrade of the housing sector.
Sign-up for Shire shares higher in London trade, but oil stocks fall investment picks
2015/1/11
By Jonathan D.
Sign-up for Shire to buy NPS Pharmaceuticals for $5.2 billion investment picks
2014/12/1
LEXINGTON, Massachusetts , December 1, 2014 /PRNewswire/ -- Company to Profile Key Late-Stage Assets Projected to Drive $3 Billion in Growth by 2020 Shire plc (LSE: SHP, NASDAQ: SHPG) announces today that it will host a live webcast in conjunction with its Research and Development (R&D) Day on Wednesday, December 10, 2014 , from 8:00 a.m. to 3:30 p.m. EST at the Alexandria Center in New York City .
Sign-up for Shire to Highlight Pipeline Progress and Breadth of Innovative Portfolio in R&D Day investment picks
2015/1/6
LEXINGTON, Massachusetts , January 6, 2015 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPG) today announced that Flemming Ornskov, MD, Chief Executive Officer, will present at the 33 rd Annual J.P. Morgan Healthcare Conference in San Francisco, CA on Tuesday, January 13, 2015 at 3:00 p.m. PT ( 6:00 p.m. ET ). A live audio webcast will be available on the Presentations and Webcasts section of Shire's Investor website at http://www.shire.com/shireplc/en/investors/presentationswebcasts .
Sign-up for Shire to Present at 33rd Annual J.P. Morgan Healthcare Conference investment picks
2015/2/25
LEXINGTON, Massachusetts , February 25, 2015 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPG) today announced that Flemming Ornskov, MD, Chief Executive Officer, will present at the Cowen 35 th Annual Healthcare Conference in Boston, MA on Tuesday, March 3, 2015 at 9:20 a.m. ET ( 2:20 p.m. GMT ). A live audio webcast will be available on the Presentations and Webcasts section of Shire's Investor website at http://www.shire.com/shireplc/en/investors/presentationswebcasts .
Sign-up for Shire to Present at the Cowen 35th Annual Healthcare Conference investment picks
2015/1/26
LEXINGTON, Massachusetts , January 26, 2015 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPG) announces that the United States Food and Drug Administration (FDA) has granted Fast Track designation for SHP609 (idursulfase-IT; also known as HGT-2310) for the treatment of neurocognitive decline associated with Hunter syndrome (mucopolysaccharidosis II or MPSII). This investigational formulation of idursulfase has been designed for direct administration into the cerebrospinal fluid via an intrathecal drug delivery device* (IDDD). This formulation is being investigated and developed for use with Shire's currently approved treatment for Hunter syndrome, ELAPRASE ® (idursulfase). ELAPRASE is administered intravenously and does not cross the blood-brain barrier in clinically relevant amounts.
Sign-up for Shire's Investigational SHP609, idursulfase-IT, Receives FDA Fast Track Designation for the Treatment of Neurocognitive Decline Associated with Hunter Syndrome investment picks
2015/2/24
Global Cosmetics Manufacturer Relies on Mobile Apps to Influence Future Product Development and Socially Connect with Each Other LAS VEGAS and TOKYO , Feb.
Sign-up for Shiseido Teams with IBM to Empower Its Beauty Consultants with Mobile Apps That Change the Way They Work investment picks
2015/1/5
The Law Offices of Vincent Wong are investigating potential claims against the Board of Directors of A.
Sign-up for SHLM SHAREHOLDER ALERT –The Law Offices of Vincent Wong Launch an Investigation into A. Schulman, Inc. investment picks
2014/12/15
Shoe Carnival, Inc. (NASDAQ: SCVL) a leading retailer of moderately priced footwear and accessories, today announced that on December 11, 2014, its Board of Directors authorized a new share repurchase program for up to $25 million of its outstanding common stock, effective January 1, 2015.
Sign-up for Shoe Carnival Announces New Share Repurchase Program investment picks
2014/12/12
Shoe Carnival, Inc. (NASDAQ: SCVL) a leading retailer of moderately priced footwear and accessories, announced today that its Board of Directors has approved the payment of a quarterly cash dividend.
Sign-up for Shoe Carnival Declares Quarterly Cash Dividend investment picks
2014/12/1
Shoe Carnival, Inc. (Nasdaq: SCVL), a leading retailer of moderately priced footwear and accessories, today reported results for the third quarter ended November 1, 2014.
Sign-up for Shoe Carnival Reports Third Quarter 2014 Results investment picks
2014/12/29
Shoe Carnival, Inc. (NASDAQ: SCVL) a leading retailer of moderately priced footwear and accessories, announced today Cliff Sifford, President and Chief Executive Officer, and Kerry Jackson, Senior Executive Vice President and Chief Operating and Financial Officer, will present at the 17 th Annual ICR XChange Conference on Monday, January 12, 2015 at 9:00 a.m. Eastern Time in Orlando, FL.
Sign-up for Shoe Carnival to Present at the 17th Annual ICR XChange Conference investment picks
2015/1/27
ShoeBuy expands into footwear manufacturing business with Micro Shoery BOSTON , Jan.
Sign-up for ShoeBuy Acquires Minority Stake in Boston Boot Company investment picks
2015/2/19
Debut of new identity celebrates company's fifteenth anniversary BOSTON , Feb.
Sign-up for ShoeBuy Opens the Box to Reveal its New Approach to Confident Online Shopping investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Shire Delivers Record Revenues and Non GAAP Earnings per ADS in 2014, and Enters 2015 With Strongest-Ever Pipeline to ShoeBuy Opens the Box to Reveal its New Approach to Confident Online Shopping
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent